Skylands Capital, LLC Cytosorbents Corp Transaction History

Skylands Capital, LLC

  • $684 Million
  • Q3 2024

A detailed history of Skylands Capital, LLC transactions in Cytosorbents Corp stock. As of the latest transaction made, Skylands Capital, LLC holds 2,755,427 shares of CTSO stock, worth $2.53 Million. This represents 0.6% of its overall portfolio holdings.

Number of Shares
2,755,427
Previous 2,840,778 3.0%
Holding current value
$2.53 Million
Previous $1.99 Million 107.9%
% of portfolio
0.6%
Previous 0.3%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024
SELL
$0.7 - $1.55 $59,745 - $132,294
-85,351 Reduced 3.0%
2,755,427 $4.13 Million
Q2 2024

Jul 26, 2024
SELL
$0.7 - $1.01 $24,341 - $35,121
-34,774 Reduced 1.21%
2,840,778 $1.99 Million
Q1 2024

May 03, 2024
SELL
$0.86 - $1.07 $325,648 - $405,167
-378,661 Reduced 11.64%
2,875,552 $2.73 Million
Q4 2023

Feb 05, 2024
BUY
$1.08 - $1.94 $334,306 - $600,513
309,543 Added 10.51%
3,254,213 $3.61 Million
Q3 2023

Oct 27, 2023
BUY
$1.86 - $4.03 $281,232 - $609,336
151,200 Added 5.41%
2,944,670 $5.54 Million
Q2 2023

Aug 03, 2023
BUY
$2.37 - $3.65 $91,245 - $140,525
38,500 Added 1.4%
2,793,470 $10 Million
Q1 2023

May 04, 2023
BUY
$1.79 - $4.17 $381,053 - $887,705
212,879 Added 8.37%
2,754,970 $9.28 Million
Q4 2022

Feb 09, 2023
BUY
$1.03 - $2.03 $200,908 - $395,965
195,057 Added 8.31%
2,542,091 $3.94 Million
Q3 2022

Nov 01, 2022
BUY
$1.2 - $2.46 $26,444 - $54,211
22,037 Added 0.95%
2,347,034 $3.19 Million
Q2 2022

Jul 28, 2022
BUY
$1.76 - $3.22 $346,799 - $634,484
197,045 Added 9.26%
2,324,997 $5.09 Million
Q1 2022

May 05, 2022
BUY
$2.88 - $4.23 $522,944 - $768,074
181,578 Added 9.33%
2,127,952 $6.79 Million
Q4 2021

Feb 08, 2022
BUY
$4.05 - $8.11 $440,773 - $882,635
108,833 Added 5.92%
1,946,374 $8.16 Million
Q3 2021

Nov 02, 2021
BUY
$7.0 - $9.71 $458,787 - $636,403
65,541 Added 3.7%
1,837,541 $14.9 Million
Q2 2021

Aug 02, 2021
BUY
$7.55 - $9.42 $1.47 Million - $1.84 Million
194,800 Added 12.35%
1,772,000 $13.4 Million
Q1 2021

May 04, 2021
BUY
$8.23 - $11.48 $409,854 - $571,704
49,800 Added 3.26%
1,577,200 $13.7 Million
Q4 2020

Feb 09, 2021
BUY
$7.65 - $8.98 $808,605 - $949,186
105,700 Added 7.43%
1,527,400 $12.2 Million
Q3 2020

Oct 27, 2020
BUY
$7.37 - $11.54 $1.69 Million - $2.64 Million
228,900 Added 19.19%
1,421,700 $11.3 Million
Q2 2020

Jul 29, 2020
BUY
$6.28 - $10.59 $417,620 - $704,235
66,500 Added 5.9%
1,192,800 $11.8 Million
Q1 2020

Apr 27, 2020
BUY
$3.77 - $7.73 $1.17 Million - $2.4 Million
310,431 Added 38.05%
1,126,300 $8.71 Million
Q4 2019

Feb 11, 2020
BUY
$3.61 - $5.22 $150,244 - $217,251
41,619 Added 5.38%
815,869 $3.14 Million
Q3 2019

Oct 29, 2019
BUY
$4.33 - $7.63 $405,504 - $714,549
93,650 Added 13.76%
774,250 $3.89 Million
Q2 2019

Jul 29, 2019
BUY
$5.92 - $7.78 $263,736 - $346,599
44,550 Added 7.0%
680,600 $4.5 Million
Q1 2019

Apr 30, 2019
BUY
$6.82 - $8.56 $956,164 - $1.2 Million
140,200 Added 28.27%
636,050 $4.82 Million
Q4 2018

Feb 07, 2019
BUY
$7.05 - $12.64 $266,490 - $477,792
37,800 Added 8.25%
495,850 $4.01 Million
Q3 2018

Oct 22, 2018
SELL
$10.95 - $14.8 $421,575 - $569,800
-38,500 Reduced 7.75%
458,050 $5.91 Million
Q2 2018

Jul 24, 2018
SELL
$6.9 - $12.35 $1.31 Million - $2.35 Million
-190,400 Reduced 27.72%
496,550 $5.66 Million
Q1 2018

Apr 19, 2018
SELL
$6.55 - $8.2 $253,209 - $316,995
-38,658 Reduced 5.33%
686,950 $4.84 Million
Q4 2017

Jan 16, 2018
BUY
$5.9 - $7.05 $1.33 Million - $1.59 Million
225,558 Added 45.11%
725,608 $4.72 Million
Q3 2017

Oct 19, 2017
BUY
$4.5 - $6.2 $2.25 Million - $3.1 Million
500,050
500,050 $3.1 Million

Others Institutions Holding CTSO

# of Institutions
58
Shares Held
17.1M
Call Options Held
10.1K
Put Options Held
500
View Full List

About Cytosorbents Corp

CTSO Quotes by TradingView
  • Ticker CTSO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 43,577,400
  • Market Cap $40.1M
  • Description
  • Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...
More about CTSO
Track This Portfolio

Track Skylands Capital, LLC Portfolio

Follow Skylands Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Skylands Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Skylands Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email